Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

Filing date Description Form Filing Group Filer View

Amendment to a previously filed 4

4/A
3,4,5
ODONNELL FRANCIS E JR 0001103021-19-000061.pdf 0001103021-19-000061.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0001103021-19-000059.pdf 0001103021-19-000059.rtf View HTML

An amendment to a SC 13D filing

SC 13D/A
Other
0000919574-19-007788.pdf 0000919574-19-007788.rtf 0000919574-19-007788.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001103021-19-000057.pdf 0001103021-19-000057.rtf 0001103021-19-000057.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Broadfin Capital, LLC 0000919574-19-007768.pdf 0000919574-19-007768.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Plesha Scott M. 0001103021-19-000054.pdf 0001103021-19-000054.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Singh Vanila 0001103021-19-000052.pdf 0001103021-19-000052.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0001103021-19-000048.pdf 0001103021-19-000048.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Cukier Herm 0001103021-19-000050.pdf 0001103021-19-000050.rtf View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Singh Vanila 0001103021-19-000047.pdf 0001103021-19-000047.rtf View HTML

Data provided by Kaleidoscope.

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon